Cargando…

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma

BACKGROUND: Multiple myeloma (MM) is a fatal malignant tumor in hematology. Mitophagy plays vital roles in the pathogenesis and drug sensitivity of MM. METHODS: We acquired transcriptomic expression data and clinical index of MM patients from NCI public database, and 36 genes involved in mitophagy f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yachun, Liu, Rui, Shi, Luyi, Feng, Yuandong, Zhang, Linlin, Guo, Ni, He, Aili, Kong, Guangyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496355/ https://www.ncbi.nlm.nih.gov/pubmed/37700273 http://dx.doi.org/10.1186/s12885-023-11371-7

Ejemplares similares

PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6
por: Jia, Yachun, et al.
Publicado: (2023)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
por: Gao, Dandan, et al.
Publicado: (2023)

Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis
por: Peng, Yue, et al.
Publicado: (2020)

Integrative Analysis of a Pyroptosis-Related Signature of Clinical and Biological Value in Multiple Myeloma
por: Wang, Huizhong, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of PACAP in Multiple Myeloma
por: Tóth, Tünde, et al.
Publicado: (2023)

The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value
por: Desantis, Vanessa, et al.
Publicado: (2022)

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma
por: Liu, Rui, et al.
Publicado: (2021)

PIWIL1 Drives Chemoresistance in Multiple Myeloma by Modulating Mitophagy and the Myeloma Stem Cell Population
por: Wang, Yajun, et al.
Publicado: (2022)

Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma
por: Li, Yongxin, et al.
Publicado: (2021)

N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21(cip1/waf1)/CDK2-Cyclin E1 axis-mediated cell cycle transition
por: Liu, Rui, et al.
Publicado: (2023)

A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer
por: Zhang, Cong, et al.
Publicado: (2022)

Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
por: Lin, Yilin, et al.
Publicado: (2021)

PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib
por: Wu, Dong, et al.
Publicado: (2021)

Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma
por: Zhao, Na, et al.
Publicado: (2023)

Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma
por: Zheng, Zhihong, et al.
Publicado: (2018)

Immunological Dysregulation in Multiple Myeloma Microenvironment
por: Romano, Alessandra, et al.
Publicado: (2014)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

Targeting the Microenvironment for Treating Multiple Myeloma
por: Neumeister, Peter, et al.
Publicado: (2022)

Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury
por: Chen, Ruo-Yang, et al.
Publicado: (2023)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
por: Guimarães, Cristina, et al.
Publicado: (2012)

CD138(-) multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient
por: Wu, Dong, et al.
Publicado: (2020)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics
por: Li, Guangyao, et al.
Publicado: (2022)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Therapeutics to harness the immune microenvironment in multiple myeloma
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma
por: Chen, Xinyi, et al.
Publicado: (2017)

Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma
por: Evers, Marietheres, et al.
Publicado: (2023)

The prognostic value and clinical significance of mitophagy-related genes in hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2022)

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma
por: Jin, Yi, et al.
Publicado: (2022)

Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma
por: Zhu, Xinying, et al.
Publicado: (2020)

Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment
por: Wang, Huizhong, et al.
Publicado: (2022)

Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
por: Wang, Jinghua, et al.
Publicado: (2022)

Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
por: García de Veas Silva, José Luis, et al.
Publicado: (2016)

RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2021)

Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
por: Berardi, Simona, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_el37lbbqorer63ajngc4j6e498